Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mehmet TÜZÜN"'
Autor:
Fulden Saraç, MD, Sebnem Parýldar, MD, Erdal Duman, MD, Fusun Saygýlý, MD, Mehmet Tüzün, MD, Candeger Yýlmaz, MD
Publikováno v:
Preventing Chronic Disease, Vol 4, Iss 3 (2007)
Externí odkaz:
https://doaj.org/article/f6d5dc0164f14f95aac56fabaf9b9a37
Autor:
Ahmet Gokhan Ozgen, Muammer Karadeniz, Mehmet Erdogan, Buket Kosova, Cumhur Gündüz, Şevki Çetinkalp, A. Kutukculer, Zuhal Eroglu, Nejat Topcuoglu, Mehmet Tüzün, Asli Tetik
Publikováno v:
Journal of Diabetes and its Complications. 22:186-190
Objective Recent studies have suggested an association between a deletion variant of the angiotensin-converting enzyme (ACE) gene and diabetic nephropathy. However, this finding has not been confirmed by all investigators. Furthermore, an M235T varia
Autor:
Taylan Kabalak, Candeger Yilmaz, Muammer Karadeniz, Nevzat Bilal, Fusun Saygili, Mehmet Tüzün, Mehmet Erdogan, Şevki Çetinkalp, Mustafa Ozbek, Ahmet Gokhan Ozgen
Publikováno v:
Journal of Diabetes and its Complications. 22:181-185
Cardiac autonomic neuropathy (CAN) is the most frequent and clinically important form of diabetic autonomic neuropathy. CAN is associated with increased frequency of other microvascular complications of diabetes mellitus (DM). In this study, we evalu
Autor:
Mustafa Ozbek, Candeger Yilmaz, Mehmet Erdogan, Mehmet Tüzün, Muammer Karadeniz, A. Gökhan Özgen, Fusun Saygili, Taylan Kabalak, Şevki Çetinkalp, Nihat Erdem
Publikováno v:
Journal of Endocrinological Investigation. 30:546-550
Background: Turkey is an endemic area for thyroid diseases. The Aegean region is well documented for increased prevalence of thyroid disorders. In this study we investigated the demographic and clinical features of subacute thyroiditis (SAT) patients
Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population
Autor:
Taylan Kabalak, Hatice Uluer, Yeşim Ertan, Muammer Karadeniz, Candeger Yilmaz, Mehmet Tüzün, Mehmet Erdogan, Afig Berdeli, Ahmet Gokhan Ozgen, Sadik Tamsel
Publikováno v:
Journal of Endocrinological Investigation. 30:411-416
Objective: Fas ligand (FasL) is an apoptotic agent and a member of tumor necrosis factor (TNF) family. FasL exists in cytotoxic T lymphocyte (CTL) and natural killer (NK) cells, and it is increased in tumor cell membrane. On the contrary, CTL and NK
Publikováno v:
Biotechnology & Biotechnological Equipment. 20:123-127
In this study, our objective was to evaluate aldosterone levels after administration of furosemide and angiotensin-converting enzyme (ACE) inhibiting drugs in hypertensive and normotensive obese women. 40 normotensive (group I) and 40 hypertensive ob
Autor:
Sercan ULUSOY, Bilgin ARDA, Fırat BAYRAKTAR, Erhan SESLİ, Mehmet Ali ÖZİNEL, Tansu YAMAZHAN, İdil ÜNAL, Gürcan KISAKOL, Mehmet TÜZÜN
Publikováno v:
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Vol 5, Iss 4, Pp 220-228 (2000)
A total of 179 patients (61 female, 118 male) with diabetic foot infection who have been followed up for 3 years (March 1997-March 2000) by the “Committee of Diabetic Foot” in Ege University Medical School, were evaluated retrospectively in vario
Autor:
A. Gökhan Özgen, Mehmet Tüzün, Enis Yetkin, Candeğer Yilmaz, Müge Tunçyürek, Firat Bayraktar, Füsun Hamulu, Taylan Kabalak
Publikováno v:
Thyroid. 9:579-582
The aims of the study were to identify medullary thyroid cancer (MTC) in its earliest stages by screening patients with basal calcitonin measurements and to determine whether basal serum calcitonin measurements should be a part of the routine evaluat
Autor:
Taylan Kabalak, Firat Bayraktar, Candeger Yilmaz, A. Gökhan Özgen, Mehmet Tüzün, Füsun Hamulu, Enis Yetkin
Publikováno v:
Endocrine Practice. 5:72-75
Objective To investigate the prevalence of triiodothyronine (T3) antibodies in patients with goiter, the influence of these antibodies on the results of thyroid hormone measurements, and the potential relationship between T3 antibodies and thyroid au
Autor:
Taylan Kabalak, Mehmet Tüzün, Firat Bayraktar, Candeger Yilmaz, Şevki Çetinkalp, Ahmet Gokhan Ozgen, Füsun Hamulu
Publikováno v:
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity. 3:136-140
Objective: Acarbose, a potent alpha-glucosidase inhibitor, provides a new concept for the treatment of metabolic disorders, and particularly diabetes mellitus. It reduces the postprandial blood glucose increment and insulin response. For this reason